In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Grant Merrill President & CEO at AES Clean Technology.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Grant, covering:
- Becoming the leader of the business that he dreamt of representing.
- The need for cleanrooms to work in an invisible way as the most critical square footage at the core of the facility.
- Having to keep up with demand during the pandemic with the swelling production needed due to covid vaccines.
- The new therapeutic areas that are driving market growth and the need to let science flourish.
- Why the CMO space is poised for growth in both drug substance and drug product.
- The simple but magical abilities of being able to communicate and building personal relationships.
Grant Merrill has been involved with cleanroom design and construction for over 25 years. He earned his BS in Mechanical Engineering from Cornell University, and then immediately entered the world of critical facilities and the mechanical systems that support them. After a successful career in the industrial HVAC engineering business, Grant joined the AES team 20 years ago. Now as President & CEO, he leads multi-disciplinary teams to deliver complex cleanroom facilities to clients throughout the life science industry.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.
We are also proudly supported by Zymewire, which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at – zymewire.com